GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the availability of the recording for the recently held fireside chat. This enlightening session, hosted by RedChip Companies on March 5, 2024, featured BullFrog AI's CEO, Vin Singh, al ...

GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced February 21, 2024, the Underwriter's decision to exercise their over-allotment option to purchase 218,382 shares of the Company's common stock (the "Option Shares"), pursuant to the Underwriti ...

GAITHERSBURG, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced its CEO, Vin Singh, alongside distinguished guest, Daniel R. Weinberger, M.D., Director and CEO of the Lieber Institute for Brain Development (LIBD), will participate in a fireside chat ...

JERSEY CITY, N.J., Feb. 5, 2024 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a technology-enabled drug development company using (AI) and machine learning to enable the successful development of pharmaceuticals and biologics , has completed its previously announced underwritten public offering of an aggregate of 1,507,139 shares of common ...

GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today the closing of an underwritten public offering of an aggregate of 1,507,139 shares of common stock (or pre-funded warrants ("Pre-Funded Warrants") in lieu thereof) and accompanying warra ...

GAITHERSBURG, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD. "We are thrilled to welcome Dr. Smith and Dr. Wala to our ...

Key PointsBullfrog AI announced positive results from a collaborative effort that may lead to significant revenue.The bfLEAP AI platform has proved helpful in finding previously unknown biological indicators for mental illness.New deals are expected soon, and a ramping revenue stream should follow, but there are risks to be aware of. 5 stocks we like better than Bullfrog AIIf Bullfrog AI NASDAQ: BFRG is not on your radar yet, it should be. This company is an emerging leader in a subset of AI that will have ...

Shares of digital technology firm Bullfrog AI (NASDAQ:BFRG) skyrocketed on Wednesday following an exciting development. Bullfrog, which specializes in leveraging machine learning to usher in a new era of precision medicine, was able to utilize its analytics technology to further the understanding and treatment of psychiatric disorders. Subsequently, BFRG stock — which has struggled since its public market debut — soared on the implications for personalized medicine in psychiatry.According to a Seeking Alpha ...

Bullfrog AI Holdings Inc (NASDAQ: BFRG) says early results of its work with the Lieber Institute for Brain Development have been positive. Its shares are up 35% at writing.Details of Bullfrog-Lieber Institute collaborationCopy link to sectionThe global strategic collaboration aims at understanding a bunch of mental disorders. Data from the Liber Institute comprised of 2,800 brain samples that encompassed psychiatric conditions like the bipolar disorder, schizophrenia, and major depressive disorder. Vin Sing ...

GAITHERSBURG, Md., Jan. 17, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG, BFRGW))) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced early results from its collaboration with the Lieber Institute for Brain Development (LIBD) that could revolutionize the understanding and treatment of psychiatric disorders. The early f ...